William Mullen
Directeur/Membre du Conseil chez NeuroTargets Ltd.
Profil
William Mullen is a Non-Executive Director of NeuroTargets Ltd.
He was Chief Executive Officer of Progeny bioVentures Limited from 1996 to 1999.
He was Chief Executive Officer of Rowett Research Services Limited.
Dr. Mullen received a BS degree in Biochemistry from the University of Sussex and a PhD in Biochemistry from the University of Bath.
Postes actifs de William Mullen
| Sociétés | Poste | Début |
|---|---|---|
NeuroTargets Ltd.
 NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Directeur/Membre du Conseil | - |
Anciens postes connus de William Mullen
| Sociétés | Poste | Fin |
|---|---|---|
Rowett Research Services Ltd.
 Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom. | President | - |
Formation de William Mullen
| University of Sussex | Undergraduate Degree |
| University of Bath | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NeuroTargets Ltd.
NeuroTargets Ltd. Pharmaceuticals: MajorHealth Technology NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK. | Health Technology |
Rowett Research Services Ltd.
Rowett Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Rowett Research Services Ltd. provided biotechnology research services. The company was founded in 1988 and was headquartered in Aberdeen, the United Kingdom. | Commercial Services |
